Overview
Amazentis is a biotech company headquartered in Lausanne, Switzerland, operating at the intersection of nutrition and pharmaceutical science to develop therapeutically validated products targeting cellular aging. The company's flagship asset, Mitopure (Urolithin A), is a proprietary postbiotic compound clinically demonstrated to activate mitophagy—the cellular recycling process—thereby improving mitochondrial function, muscle strength, and endurance in aging populations. Through its consumer health brand Timeline, Amazentis delivers science-backed nutritional interventions designed to extend healthspan by addressing fundamental hallmarks of aging, particularly mitochondrial dysfunction and cellular senescence.